Dixon, B. S., Greene, T., Beck, G. J., Dember, L. M., Gassman, J. J., Himmelfarb, J., … Feldman, H. I. (2002). Dialysis access consortium (DAC) trial design: Sustained-release dipyridamole plus aspirin (D/A) to prevent graft failure. In JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (Vol. 13, pp. 232A-232A). LIPPINCOTT WILLIAMS & WILKINS.

Dixon, B. S., T. Greene, G. J. Beck, L. M. Dember, J. J. Gassman, J. Himmelfarb, L. G. Hunsicker, et al. “Dialysis access consortium (DAC) trial design: Sustained-release dipyridamole plus aspirin (D/A) to prevent graft failure.” In JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 13:232A-232A. LIPPINCOTT WILLIAMS & WILKINS, 2002.

Dixon BS, Greene T, Beck GJ, Dember LM, Gassman JJ, Himmelfarb J, et al. Dialysis access consortium (DAC) trial design: Sustained-release dipyridamole plus aspirin (D/A) to prevent graft failure. In: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2002. p. 232A-232A.

Dixon, B. S., et al. “Dialysis access consortium (DAC) trial design: Sustained-release dipyridamole plus aspirin (D/A) to prevent graft failure.” JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, vol. 13, LIPPINCOTT WILLIAMS & WILKINS, 2002, pp. 232A-232A.

Dixon BS, Greene T, Beck GJ, Dember LM, Gassman JJ, Himmelfarb J, Hunsicker LG, Kaufman J, Kusek JW, Middleton JP, Schwab SJ, Feldman HI. Dialysis access consortium (DAC) trial design: Sustained-release dipyridamole plus aspirin (D/A) to prevent graft failure. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2002. p. 232A-232A.